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Summary
Sustained signaling from the T cell receptor (TCR)
and costimulatory molecules is thought necessary for
generating high numbers of effector T cells. Here, we
show that Survivin is controlled in peripheral T cells
by OX40 cosignaling via sustained PI3k and PKB acti-
vation. Survivin is induced by OX40 independent of
mitotic progression in late G1, and blocking Survivin
suppresses S-phase transition and division of T cells
and leads to apoptosis. Moreover, Survivin expres-
sion alone is sufficient to restore proliferation and to
antagonize apoptosis in costimulation-deficient T
cells and can rescue T cell expansion in vivo. Survivin
allows effector T cells to accumulate in large num-
bers, but Bcl-2 family proteins are required for T cell
survival after the phase of active division. Thus, sus-
tained Survivin expression from costimulatory signal-
ing maintains T cell division over time and regulates
the extent of clonal expansion.
Introduction
It is well documented that costimulatory molecules in
the Ig and tumor necrosis factor receptor (TNFR) super-
families synergize with antigen signals to drive efficient
T cell clonal expansion (Croft, 2003; Sharpe and Free-
man, 2002), but the intracellular targets of cosignals
have not been fully delineated. Sustained signaling,
from 2 to 10 hr, can control the ability to initiate the
division process (Iezzi et al., 1998; van Stipdonk et al.,
2001), and phosphatidylinositol-3-kinase (PI3k) and
protein kinase B (PKB [Akt]) activation can account for
much of this requirement for commencing proliferation
(Costello et al., 2002; Harriague and Bismuth, 2002;
Huppa et al., 2003). These signals derive from the TCR
and constitutively expressed receptors such as CD28
(Dahl et al., 2000; Jones et al., 2002; Kane et al., 2001;
Parry et al., 1997). In contrast, additional costimulatory
molecules that are inducible, such as the TNFR family
member OX40 (CD134), are also essential for T cell re-
sponses (Croft, 2003). OX40 is expressed from 12 to 24
hr after activation of naive T cells (Gramaglia et al.,
1998). Similarly, OX40L is induced on antigen-pre-
senting cells (APC) hours or days after activation (Oh-
shima et al., 1997; Rogers et al., 2001). Efficient ex-*Correspondence: mick@liai.orgpression of both OX40 and OX40L requires CD28-B7
interactions (Rogers et al., 2001; Walker et al., 1999),
and T cells lacking OX40 initially divide normally but
do not maintain division over time and eventually die
(Rogers et al., 2001).
Recently we showed that sustained PKB signaling af-
ter OX40 engagement, over a period of several days,
was required for prolonging T cell expansion and T cell
survival (Song et al., 2004). This correlated with other
data showing sustained signaling over several days
was required for efficient accumulation of T cells (Gett
et al., 2003). Although the long-term survival action of
OX40 can be explained through maintaining high levels
of antiapoptotic Bcl-2 family members (Rogers et al.,
2001; Song et al., 2004), the proliferation of effector
cells over time (Gramaglia et al., 1998; Rogers et al., 2001)
might be regulated some other way. This prompted us
to search for a molecule that is maintained over a
period of several days, targeted by OX40, which could
be essential for clonal expansion.
Through an initial gene chip screen, we identified
Survivin (Altieri, 2003; Ambrosini et al., 1997), an inhibi-
tor of apoptosis (IAP) family member, as a potential
target of OX40. IAPs include c-IAP1, c-IAP2, and XIAP,
and these have been described to counteract apopto-
sis induced by a number of stimuli such as anti-Fas,
TNF, chemotherapeutic agents, and exposure to UV ra-
diation (Reed and Bischoff, 2000). The majority of tumor
cells express Survivin, and two main activities have
been described: inhibition of apoptosis and regulation
of cell cycle progression (Li et al., 1999, 1998; Tamm et
al., 1998; Uren et al., 2000). Survivin can be expressed
in activated, mature, and transformed T cells (Kor-
nacker et al., 2001; Shon et al., 2003), but physiological
data on function is limited. Two recent studies that con-
ditionally deleted Survivin in the T lineage showed that
thymocytes were blocked in progressing through the
cell cycle, which ultimately led to death of most cells
as they tried to transition from CD4−CD8− DN to CD4+
CD8+ DP (Okada et al., 2004; Xing et al., 2004).
Here, we show that Survivin expression in mature
antigen-responding CD4 T cells is regulated after
PKB(Akt) activation from OX40 and that sustained Sur-
vivin expression is required to maintain T cell prolifera-
tion while at the same time antagonizing apoptosis. We
show that Survivin regulates G1/S transition in T cells
but is not expressed once division ends. Our studies
demonstrate that sustained Survivin expression is
essential to the accumulation of high frequencies of ef-
fector T cells, and they define another target for costim-
ulatory molecules.
Results
OX40-Deficient T Cells Are Impaired
in Expressing Survivin
We previously used an in vitro system combined with
adoptive transfer of T cells in vivo to dissect the
requirements for costimulatory signals to mature CD4
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622cells with antigen-specific cells from TCR transgenic a
bmice (Gramaglia et al., 1998; Rogers et al., 2001; Song
et al., 2004). As reported before, sustained proliferation r
sof recently activated T cells is dependent on OX40 (Fig-
ure 1A). Immunoblots were performed on lysates from e
anaive wild-type (wt) or OX40-deficient T cells stimulated
with peptide over 8 days (Figure 1B). Survivin was not l
edetected in naive T cells but was upregulated after acti-
vation, corresponding to the period of cell division. Ex-
tpression of Survivin was substantially lower in OX40 KO
T cells. Supporting the idea that OX40 signaling is re- f
squired to maintain Survivin expression over time, wt T
cell cultures were supplemented with an agonist anti- n
aOX40, which augmented expression from days 4 to 8
(Figure 1C). These changes were not generalized phe- f
1nomena, as other proteins associated with the cell cy-
cle, such as cyclin E, cyclin D, and CDK2, or proteins a
cassociated with signaling, such as Erk and p38 MAP
kinases, did not differ compared to wt T cells (Figure t
1B and data not shown, or see Song et al., [2004]). Ad-
ditionally, the total levels of expression (Figure 1B) and rFigure 1. Defective Survivin Expression in the Absence of OX40
CD4 T cells from wt or OX40 KO AND TCR transgenic mice were stimulated in vitro with APCs and peptide.
(A) Naive T cell proliferation over 7 days. Data are mean thymidine incorporation ±SD in triplicate cultures and are representative of three ex-
periments.
(B and C) Naive T cell Survivin expression after stimulation of wt or KO T cells (B) or wt T cells in the presence of agonist anti-OX40 (C).
Relative levels of Survivin over time are shown compared to peak levels in wt T cells (value of 1) based on densitometric scans. Similar data
were obtained in two to four experiments.
(D) Survivin expression in primed T cells. Naive wt or OX40 KO T cells were stimulated with anti-CD3 and CD28 for 7 days. The primed T
cells were restimulated with Ag and APCs, and Survivin, Cyclin E, Cyclin D, CDK2, and Aurora B visualized. Similar data were obtained in
three experiments.
(E and F) Survivin intracellular staining, after labeling naive wt or OX40 KO T cells with CFSE and stimulating with Ag/APCs (E). Quantification
of percent Survivin-positive cells in each division on day 5 (F). Data are representative of three experiments. Data are mean ± SD from
triplicate cultures.ctivity (not shown) of Aurora B kinase—a putative
inding partner of Survivin and a molecule thought to
egulate mitosis (Bolton et al., 2002)—were not changed,
uggesting further specificity. Correlating with our
arlier data on OX40 signals being required for effector
nd/or memory responses (Gramaglia et al., 1998; Sa-
ek-Ardakani et al., 2003), reexpression of Survivin in
ffector T cells was also impaired (Figure 1D).
By prelabeling T cells with carboxyfluorescein diace-
ate succinimidyl ester (CFSE), we found that only a
raction of cells going through each round of division
tained for Survivin by intracellular flow cytometry. The
umber of Survivin-expressing cells was reduced in the
bsence of OX40, even though the overall division pro-
ile based on CFSE staining was altered little (Figures
E and 1F). The deficiency again was most obvious late
fter day 3 and in cells that had divided several times,
orrelating with the induced expression of OX40 and
he results assessing thymidine incorporation.
We previously demonstrated that a CD28 deficiency
epresents a combined CD28 and OX40 deficiency, and
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(Rogers et al., 2001). Analysis of CD28 KO T cells also
revealed a strong defect in Survivin expression; how-
ever, this was accompanied by many defects, such as
reduced levels of cyclin D, cyclin E, CDK2, and Aurora
B (see Figure S1 in the Supplemental Data available
with this article online).
Sustained PKB Activation Maintains
Survivin Expression
Previous data in non-T cells associated Survivin with
PI3k and PKB (Fornaro et al., 2003; Ohashi et al., 2004),
and OX40:OX40L interactions maintain PI3k:PKB acti-
vation over time (Song et al., 2004). To investigate if
this linked OX40 with Survivin, OX40 KO T cells were
activated with antigen for 2 days and then transduced
with active (myr) PKB in a retroviral vector (Song et al.,
2004). Significantly, active PKB fully restored Survivin
expression in OX40 KO T cells (Figure 2A). Survivin can
also be phosphorylated on Thr34, and this has been
correlated with the total levels of Survivin in malignant
cells (Grossman et al., 2001; O’Connor et al., 2000). Im-
munoprecipitation revealed lower levels of phosphory-
lated Survivin in OX40 KO T cells, and levels were in-
creased to those in wt T cells after transduction of
active PKB (Figure 2B). Furthermore, dominant-nega-
tive PKB (Song et al., 2004) in wt T cells strongly inhib-
ited Survivin (Figure 2C). Blocking PI3k late with the
inhibitor LY294002 for a 24 hr period from days 2 to 3
or days 3 to 4 during the primary wt T cell culture also
inhibited Survivin (Figure 2D). Similarly, blocking PI3k in
effector cells suppressed reexpression of Survivin after
secondary antigen exposure (Figure 2E). Collectively,
this supports the idea that sustained or periodic PKB
activation is necessary to maintain Survivin over time.Figure 2. PKB Regulates Survivin
Naive CD4 cells from wt or OX40 KO AND
mice were stimulated with peptide and
APCs. On day 2 and 3, T cells were trans-
duced with retroviral vectors expressing
GFP alone (Mig), GFP with myristoylated
PKB (Mig-myr-PKB) (A and B, wt and OX40
KO), or GFP with dominant-negative PKB
(Mig-dn-PKB) (C, wt).
(A and C) On day 6 of primary culture, GFP+
CD4 cells were sorted, and lysates were ana-
lyzed for Survivin and PKB.
(B) On day 6 of primary culture, GFP+ CD4
cells were sorted, lysates were immunopre-
cipitated with anti-Survivin and analyzed for
phosphorylated threonine.
(D) Naive wt T cells were stimulated with
peptide and APCs, and LY294002 was added
for the last 24 hr of culture (days 2–3 or 3–4).
Survivin expression was determined at the
end of the 24 hr period.
(E) Activated wt T cells, taken after 7 days
of primary culture, were restimulated with
peptide/APCs in the presence of DMSO,
LY294002, or Wortmannin added at time 0 hr.
Survivin expression was determined after 1
or 2 days. All data are representative of two
experiments.Survivin Is Expressed in Late G1 and Regulated
by OX40 Signals
Published studies of cancer/transformed cells have re-
ported that Survivin is predominantly expressed during
mitosis (Kobayashi et al., 1999; Li et al., 1998). However,
other reports suggested it might be active and ex-
pressed earlier in the G1 phase of the cell cycle (Fu-
kuda and Pelus, 2001; Suzuki et al., 2000a). By costain-
ing with BrdU and 7-AAD, we visualized Survivin
expression in all phases of the T cell cycle. However,
many Survivin-positive cells were in G1, before S phase
transition (Figure 3A). Correlating with this, hydroxyurea
and aphidocolin, inhibitors of S phase progression, and
nocodazole, an inhibitor of G2/M, reduced only to a de-
gree the total number of cells expressing Survivin.
To show that OX40 had a direct effect on regulating
Survivin, wt effector T cells, taken when OX40 was still
expressed, were restimulated with agonist anti-OX40 in
the absence of any other signals (Figures 3B–3D). Sur-
vivin was expressed after triggering OX40, and this was
not dependent on cell division, as significant expres-
sion was retained in the presence of hydroxyurea,
aphidicolin, and nocodazole (Figure 3B). Anti-OX40
upregulated Survivin message, and this was not af-
fected by the cell cycle inhibitors (Figure 3C). Survivin
mRNA expression was also not dependent on new pro-
tein synthesis in these primed T cells, as induction was
apparent in the presence of cyclohexamide but was
completely blocked by a PI3k inhibitor (Figure 3D).
Survivin Is Sufficient to Rescue T Cell Expansion
Associated with an OX40 Deficiency
To determine if a lack of Survivin was responsible for
defective proliferation of OX40-deficient T cells, we ret-
rovirally transduced T cells with wt Survivin (Mig-Sur-
vivin). Tracking the total number of GFP+ cells showed
Immunity
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(A) Naive CD4 T cells from wt AND mice were stimulated with Ag and APCs in the presence of DMSO (control), Hydroxyurea, Aphidicolin, or
Nocodazole added at time 0 hr. After 2 days, Survivin expression was analyzed in various phases of the cell cycle after BrdU pulsing and
7-AAD staining. Left: cell cycle analysis shown in red with Survivin expression overlaid in blue, after gating on CD4 cells. Right: total percent
Survivin expression in CD4 cells.
(B–D) Survivin induction in effector T cells. Wt effector T cells taken after 7–11 days of primary culture were stimulated for 24 hr with agonist
anti-OX40 alone or control IgG in the presence of DMSO, Hydroxyurea, Aphidicolin, or Nocodazole (B and C); or DMSO, ethanol, cyclohexa-
mide (CHX), or LY294002 (D), added at time 0 hr. Survivin expression by intracellular staining (B) and RT-PCR (C and D). Similar data were
obtained in one repeat experiment. Errors are mean ± SD from triplicate PCR wells.rescued numbers of OX40 KO T cells expressing wt K
iSurvivin in vitro similar to the recovery of wt T cells
(Figure 4A). This was accompanied by sustained divi- o
fsion of OX40-deficient T cells during this period, as
measured by incorporation of thymidine (Figure 4B) and s
eby decreased numbers of apoptotic cells (Figure 4C).
Similar results were seen when effector T cells from pri- t
mary cultures were sorted and restimulated with anti-
gen. OX40 KO cells transduced with wt Survivin dis- v
Splayed enhanced recovery where the OX40 deficiency
was evident (Figure 4D), and this correlated with aug- C
nmented accumulation of cells in the S and G2/M
phases of the cell cycle (Figure 4E). In particular, Sur- r
Ovivin promoted a shift out of G1 and fully restored S
phase transition, directly correlating with data showing c
fthat the majority of Survivin was expressed at the G1/S
border (Figure 3A). a
CTo show that Survivin expression alone was sufficient
to reverse the defective proliferation of OX40-deficient a
iT cells in a more physiological setting, GFP-sorted T
cells were adoptively transferred into syngeneic recipi- v
cents, which were then immunized (Figure 5). OX40 KO
T cells expanded less than wt T cells over 3 days, and
this was rescued by Survivin. The OX40 defect was S
Amore evident at 7 days, and expression of wt Survivin
reversed this and resulted in 4- to 5-fold higher num- o
ebers of T cells being visualized (Figure 5A). Analysis of
cell division and apoptosis in vivo, by either prelabeling p
iT cells with PKH26, a dye that dilutes with cell division
(Figure 5B, left); or with an in vivo BrdU pulse (Figure F
c5B, middle), or with annexin staining (Figure 5B, right),
supported the in vitro conclusions. Wt Survivin in OX40 sO T cells resulted in more T cells going through vary-
ng numbers of divisions and enhanced the proportion
f T cells that divided. Division was accompanied by
ewer T cells undergoing apoptosis. Overall, these data
trongly support the conclusion that sustained Survivin
xpression through OX40:OX40L interaction is required
o maintain T cell division over time.
CD28 crosslinking in isolation also upregulated Sur-
ivin protein and message in effector T cells (see Figure
2). Unlike naive T cells (Figure S1), stimulation of
D28-deficient effector T cells with antigen showed
ormal expression of cyclin E, cyclin D, CDK2, and Au-
ora B, but Survivin was strongly impaired. Similar to
X40-deficient T cells, wt –Survivin augmented cell cy-
le progression and proliferation in CD28-deficient ef-
ector T cells in vitro and partially rescued defective
ccumulation, enhancing the proportion of dividing
D28 KO T cells and reducing the number undergoing
poptosis (Figure S2). The action was not as strong as
n OX40 KO T cells (Figure 5), likely reflecting that Sur-
ivin does not solely account for CD28 action during
lonal division.
urvivin Cannot Promote Long-Term T Cell Survival
lack of OX40 signals results in defective expression
f antiapoptotic members of the Bcl-2 family (Rogers
t al., 2001; Song et al., 2004). Augmented expansion
romoted by Survivin was not accompanied by changes
n expression of Bcl-2 and Bcl-xL, which, as shown in
igure 6A, were not maintained. To see if Survivin could
ompensate for a lack of these molecules, T cell re-
ponses similar to those above were extended to en-
Survivin Sustains T Cell Expansion
625Figure 4. Survivin Rescues Proliferation and Death of OX40-Deficient T Cells In Vitro
CD4 T cells from wt or OX40 KO AND mice were stimulated with peptide and APCs, and transduced on days 2 and 3 with retroviral vectors
expressing GFP (Mig) or GFP with wt Survivin (Mig-Survivin).
(A) Primary T cell survival on day 8 after reculturing unsorted T cells without further stimulation on day 3. Data show percent recovery
calculated based on assigning the input number of GFP+ cells in each culture as 100%. Data are mean ± SD from three experiments. Cell
lysates were analyzed by immunoblotting for Survivin (top).
(B) Primary proliferation on day 4 and day 8 measured in unseparated cultures by pulsing with thymidine for the last 20 hr. Data are mean ±
SD from triplicate cultures and are representative of three experiments.
(C) Primary apoptosis on day 6 measured in unseparated cultures by gating on CD4+ cells (GFP+ and GFP−) and staining with annexin V.
Open histograms are unstained cells. Data are representative of three experiments.
(D) Recall T cell survival after sorting GFP+CD4 cells on day 6 and restimulating with peptide and APCs in a secondary response. Data show
percent recovery calculated based on the input number of cells. Results are mean ± SD from three experiments.
(E) Recall T cell cycle progression, measured with a 1 hr BrdU pulse and 7-AAD staining, after sorting GFP+CD4 cells and restimulating with
peptide/APCs in a secondary response for 3 days. Similar data were obtained in one repeat experiment.compass a time after the expansion and division phase
ended. This demonstrated a strikingly different result.
In vitro at day 12 of secondary cultures (Figure 6B) or
in vivo 14 days after immunization, when clonal con-
traction had occurred (compare scales in Figure 5A to
Figure 6C), no difference in recovery was observed with
wt Survivin-transduced cells. Thus, Survivin can control
the frequency of effector T cells generated during
clonal division, but, in the absence of Bcl-2 antiapo-
ptotic proteins, Survivin cannot result in T cell persis-
tence after division has terminated.
Survivin Controls In Vivo Antigen-Driven
Clonal Expansion
To formally show the requirement for Survivin in anti-
gen-specific T cell responses, we used a retroviral vec-
tor containing a mutant nonphosphorylatable Survivin
(T34A) that behaves as a dominant negative (Grossman
et al., 2001; O’Connor et al., 2000; Wall et al., 2003).
Immunoblots showed reduced levels of endogenous
Survivin after expression of this mutant but, importantly,
showed no effect on Bcl-xL and Bcl-2 (Figure 7A).
In vitro, after restimulation with antigen, T cells ex-pressing T34A-Survivin were impaired in expanding
(Figure 7B) and displayed reduced proliferation, as
measured by thymidine incorporation (Figure 7C), or re-
duced cell cycle progression, with the major effect be-
ing suppression of cells in S phase (Figure 7D). In vivo,
T cells expressing T34A-Survivin were defective in ex-
panding at 3 days, and reduced numbers were main-
tained through to day 7 such that 60%–70% fewer cells
were detected (Figure 7E). Analysis of cell division
showed fewer T34A-Survivin-expressing cells dividing
and elevated numbers of apoptotic cells (Figure 7F).
Collectively, this provides strong evidence that Survivin
is required for efficient T cell responses and that sus-
tained Survivin expression through costimulatory sig-
naling over several days is critical to the magnitude of
clonal expansion.
Discussion
The results in this paper describe a target molecule,
Survivin, whose expression in T cells depends on co-
stimulation and sustained and/or periodic PKB cosig-
nals. Whereas it is accepted that Survivin can affect
Immunity
626Figure 5. Survivin Restores Defective Expan-
sion of OX40-Deficient T Cells In Vivo
CD4 T cells from wt or OX40 KO OT-II mice
were stimulated with peptide in vitro and
transduced on days 2/3 with retroviral vec-
tors expressing GFP (Mig) or GFP with wt
Survivin (Mig-Survivin). After 6 days, GFP+
CD4 cells were sorted, labeled with PKH26,
and adoptively transferred to syngeneic re-
cipients. Mice were challenged with OVA in
PBS (closed histograms) or PBS without an-
tigen (open histograms).
(A) T cell expansion after 3 and 7 days, with
the number of GFP+Vβ5+CD4+ cells enumer-
ated in the spleen and lymph nodes. Data
are mean response ± SD from three indivi-
dual mice per group and are representative
of three experiments.
(B) Division of transferred T cells was moni-
tored for 3 days after challenge by determin-
ing either the extent of dilution of PKH26
(left) or the incorporation of BrdU after an in
vivo pulse for 2 days (middle). Apoptosis
was measured by annexin V staining after
gating on Vβ5+CD4+ (GFP+ and GFP−) cells
(right). Bold line, Mig-Survivin group; dashed
line, Mig-control group. Shaded histograms
are recipients of Mig-Survivin T cells injected
with PBS. Data are representative of three
experiments.propose that Survivin might associate with moleculesmagnitude and longevity of T cell responses.
Figure 6. Survivin Does Not Sustain Long-Term CD4 T Cell Survival
CD4 T cells from wt or OX40 KO AND mice were stimulated with peptide and transduced with retroviral vectors on day 2/3.
(A) Expression of total (human/mouse) and endogenous (mouse) Survivin and Bcl-2-like proteins on day 6 in lysates of GFP+CD4+-sorted cells.
(B) In vitro recall T cell recovery after 12 days of secondary culture after sorting GFP+CD4 cells and restimulating with peptide. Data show
mean percent recovery ± SD calculated based on the input number of cells.
(C) In vivo T cell recovery 14 days after immunization, after sorting GFP+CD4 cells, adoptively transferring to syngeneic recipients, and
challenging with PCC in PBS (closed histograms) or PBS alone (open histograms). Data are mean number of GFP+Vβ3+CD4+ cells ± SD
enumerated in the spleen and lymph nodes from three individual mice per group. Results representative of two or three experiments.cell cycle progression, our work demonstrates that the
Sregulation of Survivin expression is a key feature of the
control of peripheral T cell proliferation to antigen. We s
cshow that expression of Survivin not only is necessary
but also is sufficient to promote T cell proliferation and F
sto antagonize apoptosis in activated T cells. The results
provide novel insights into the process by which T cells b
crespond and the intracellular molecules that are key to
controlling division, life, and death, and, hence, the aThere has been much debate over the exact role of
urvivin in cells, and whether it functions to directly
uppress apoptosis or whether it regulates the cell cy-
le (Altieri, 2003; Reed, 2001; Reed and Bischoff, 2000).
or example, data from transformed non-T cells have
uggested that Survivin might inhibit apoptosis by
inding and sequestering a number of caspase mole-
ules (Li et al., 1999; O’Connor et al., 2000; Suzuki et
l., 2000b; Tamm et al., 1998). In contrast, other data
Survivin Sustains T Cell Expansion
627Figure 7. Dominant-Negative Survivin Inhibits T Cell Expansion
CD4 T cells from wt OT-II TCR transgenic mice were stimulated with peptide/APCs and transduced with retroviral vectors expressing GFP
(Mig) or GFP with dominant-negative Survivin (Mig-T34A-Survivin).
(A) Expression of total (human and mouse) and endogenous (mouse) Survivin, Bcl-xL, and Bcl-2, in GFP/CD4-sorted cells on day 6.
(B–D) In vitro response. T cell expansion (B) based on enumerating GFP+ cells and expressed as percent of input number, proliferation (C)
based on incorporation of thymidine, and cell cycle progression (D) based on BrdU/7-AAD staining, all after in vitro restimulation of GFP/
CD4-sorted cells. Data are representative of two or three experiments. Errors indicate mean ± SD of triplicate cultures.
(E and F) In vivo response. GFP+CD4+ T cells were sorted, labeled with PKH26, and adoptively transferred into naive syngeneic recipients.
Mice were challenged with OVA in PBS (closed histograms) or PBS alone (open histograms). (E) T cell expansion after 3 or 7 days to assess
the number of GFP+/Vβ5+/CD4+ cells in combined spleen and lymph nodes. Data are mean ± SD from three individual mice per group and
are representative of three experiments. (F) Cell division or apoptosis after 3 days by determining the extent of dilution of PKH26 (top) and
incorporation of BrdU after a 2 day pulse (middle) after gating on Vβ5+GFP+ cells; and staining for annexin V after gating on Vβ5+CD4+ (GFP+
and GFP−) cells. Bold line, Mig control; dashed line, Mig-T34A-Survivin. Shaded histograms are profiles from recipients of Mig-T34A-Survivin
T cells injected with PBS. Data are representative of three experiments.necessary for cell division, such as Aurora B kinase,
which regulates mitosis and chromosome segregation
(Bolton et al., 2002), or cyclin-dependent kinases such
as Cdk4, which regulate early cell cycle progression
(Suzuki et al., 2000a). Additionally, recent results with
Survivin-deficient thymocytes showed that apoptosis,
mediated by anti-Fas, chemotherapeutic agents, or ex-
posure to UV radiation, was not affected in its absence
(Okada et al., 2004; Xing et al., 2004), arguing against
Survivin regulating induced cell death.
In nonlymphoid cancer cells, Survivin can associate
with mitotic spindle microtubules and centromeres (Li
et al., 1998; Uren et al., 2000), and Survivin knockout
embryos die at 4.5 days post coitum, exhibiting dis-
rupted microtubule formation (Uren et al., 2000). Simi-
larly, mutations in Survivin, antisense, or dominant-
negative Survivin affect interactions with microtubules
in transformed cells that ultimately lead to enhanced
cell death (Li et al., 1999, 1998). This has been interpre-
ted as showing that Survivin controls mitosis in trans-
formed cells and correlates with the notion that in such
cells, Survivin is largely G2/M associated. In contrast,our data clearly show that Survivin is expressed in G1
in primary T cells as well as other phases of the cell
cycle. This G1 expression has also been observed in
primary hematopoietic cells (Fukuda and Pelus, 2001)
and correlates with the idea that Survivin can associate
with cyclin-dependent kinases such as Cdk4 and Cdk2
that regulate G1 to S transition (Suzuki et al., 2000a).
Aurora B expression was not altered in the absence of
OX40 and Survivin expression and function were asso-
ciated with a phase of the cell cycle before mitosis and
before Aurora B is thought to be active. These data are
consistent with the idea that a principal function of Sur-
vivin in antigen-responding T cells is to control early
phases of cell cycle progression. In line with this, we
showed that forced expression of Survivin largely res-
cued defective expansion of OX40 KO T cells and also
restored G1 to S transition and reduced apoptosis. Al-
though one could argue that this might not reflect the
physiological activity of Survivin, our results with domi-
nant-negative Survivin showed a reciprocal phenotype
in that inhibition of endogenous Survivin expression
blocked movement through S phase, reduced the num-
Immunity
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death. w
Of closest relevance to the results here are studies p
showing a block in thymocyte development when Sur- t
vivin was deleted in the T lineage (Okada et al., 2004; c
Xing et al., 2004). This was accompanied by reduced c
numbers of cells in S phase of the cell cycle and en- s
hanced apoptosis (Okada et al., 2004). In addition, in w
a mouse engineered to allow Survivin deletion in the d
thymus, but after the DP transition, the Survivin defi- i
ciency resulted in reduced numbers of peripheral T c
cells, and they exhibited a semimature phenotype. Al- p
though some differences were apparent between these i
peripheral T cells stimulated with mitogens compared m
to homeostatically responding Survivin-deficient thy- u
mocytes, a block in S phase progression appeared to t
be common to both when cell cycle analysis was per- S
formed (Xing et al., 2004). This directly correlates with s
our observation that the majority of Survivin-expressing t
T cells were at the G1/S border and that Survivin could e
be induced by OX40 signals independent of mitotic S
progression, even when S and G2/M were inhibited. o
This again strongly argues that a major role of Survivin
in antigen-responding T cells is to allow them to con- d
tinue dividing rather than to undergo apoptosis. n
Data over the past few years have highlighted the M
need for multiple Ig and TNFR:TNF costimulatory re- t
ceptor-ligand interactions for immunogenic T cell re- l
sponses. (Croft, 2003; Sharpe and Freeman, 2002; l
Alegre et al., 2001). We recently described a common m
link between CD28 (Jones et al., 2002; Kane et al., 2001) i
and OX40 in that they functioned temporally over sev- t
eral days to activate pathways leading through PKB e
(Rogers et al., 2001; Song et al., 2004). Together with
data that measured the time of stimulation needed for
Eproliferation (Iezzi et al., 1998; van Stipdonk et al., 2001;
Gett et al., 2003), this has promoted the concept that
Msustained signaling and sustained expression of effec-
A
tor molecules are essential to the longevity of T cell c
responses. PKB activation has been described to posi- d
tively affect the levels of antiapoptotic Bcl-2 family m
members (Jones et al., 2000; Pugazhenthi et al., 2000; t
wSong et al., 2004), to enhance glucose metabolism
w(Frauwirth et al., 2002; Plas et al., 2001), and to sup-
press expression or activity of proapoptotic molecules
such as Bim and Bad (Datta et al., 1997; Dijkers et al., P
2002)—all activities implicated in promoting effective T T
cell immunity. Our results now show that Survivin ex- s
cpression in T cells is also regulated by sustained PI3k
Pand PKB signals, correlating with reports of non-T cells
S(Fornaro et al., 2003; Ohashi et al., 2004). We then sug-
wgest that this provides a functional link to the studies
W
that have argued that sustained PI3k:PKB activation N
controls initial naive T cell proliferation (Costello et al., A
2002; Harriague and Bismuth, 2002; Huppa et al., 2003) f
and explains why continued costimulation and PKB ac- f
Stivation through TNFR-family molecules result in long-
Bterm T cell division.
(OX40 and CD28 can affect the expression of Bcl-2,
(Bcl-xL, and Bfl-1 (Rogers et al., 2001; Song et al., 2004;
o
Boise et al., 1995; Dahl et al., 2000; Radvanyi et al., e
1996). Interestingly, Survivin is also induced after T cell i
activation, similar to the time when Bcl-xL and Bfl-1 (
Aare highly expressed, but it is not detected in naive oremory T cells, in contrast with these molecules and
ith Bcl-2 (Figure 1 [Kornacker et al., 2001]). This im-
lies that it is more tightly controlled, and the correla-
ion between Survivin expression and the period of T
ell division suggests that it is only important when T
ells are actively going through the cell cycle. This is
upported by the fact that expression of wt Survivin
as sufficient to rescue defective expansion of OX40-
eficient T cells over a week of antigen stimulation, but
t did not restore to normal numbers the frequency of T
ells that persisted over the long-term as memory or
rememory cells. That the OX40 KO T cells were still
mpaired in expressing the antiapoptotic Bcl-2 family
olecules suggests that the majority of the costim-
lation-deficient effector T cells induced by Survivin
ransduction died once clonal division terminated. Thus,
urvivin function is restricted to the period of T cell divi-
ion, whereas the Bcl-2 family molecules that are main-
ained at low/medium levels in memory cells (Grayson
t al., 2000; Rogers et al., 2001; Schluns et al., 2000;
ong et al., 2004) most likely regulate T cells through-
ut and beyond the antigen recognition period.
In conclusion, we show that Survivin is a central me-
iator of antigen-induced T cell division and antago-
izes apoptosis during the T cell-expansion phase.
oreover, expression of Survivin is controlled by sus-
ained and/or periodic costimulatory signaling and re-
ies on activation of the kinase PKB. These data high-
ight the complexity of the T cell response and how
ultiple membrane-expressed receptors and multiple
ntracellular target molecules synergize in a process
hat is maintained over a number of days after antigen
ncounter.
xperimental Procedures
ice
ND TCR transgenic mice (wt), containing Vβ3/Vα11 expressing T
ells reactive with M/PCC, were on a B10.BR background. OX40
eficient (OX40 KO) and CD28 deficient (CD28 KO) AND transgenic
ice were generated as before (Rogers et al., 2001). OT-II TCR
ransgenic mice, containing Vβ5/Vα2 expressing T cells reactive
ith OVA, were on a BL/6 background. OX40-deficient OT-II mice
ere bred as before (Song et al., 2004).
eptides, Chemicals, and Antibodies
102S, superagonist of MCC (88–103), and OVA (323–339) were
ynthesized at La Jolla Institute for Allergy and Immunology. Cyto-
hrome c from pigeon (PCC, c-4011), ovalbumin (OVA, A5503-10G),
KH26-GL, DMSO (D2438), and mitomycin c (M-0503) were from
igma. 5- and 6-carboxyfluorescein diacetate succinimidyl ester
ere from Molecular Probes (CFSE, C-1157). LY294002 (440202),
ortmannin (681675), Hyroxyurea (400046), Aphidicolin (178273),
ocodazole (487928), and Cyclohexamide were from Calbiochem.
nti-OX40 (OX86) was produced in house. Anti-CD28 (37.51) was
rom BD Pharmingen. Anti-human/mouse Survivin (D-8, sc-17779)
or Western blotting analysis was from Santa Cruz Biotech. Anti-
urvivin (NB 500-201) for immunoprecipitation was from Novus-
iologicals. Anti-mouse Survivin (ab8113) was from Abcam Ltd.
Cambridge, MA). Bcl-xL (2762), Bcl-2 (2872), phospho-threonine
p-Thr-polyclonal, 9381), peroxidase-conjugated anti-rabbit (7054),
r anti-mouse Ig (7056) were from Cell Signaling Technology (Bev-
rly, MA). BrdU flow kit, all FITC-, PE-, and Cyt-conjugated antibod-
es, were from BD Pharmingen. Actin was from ICN Biomedical
C4). Anti-Cyclin E (M-20, sc-481) was from Santa Cruz Biotech.
nti-Aurora B (ab2254) was from Abcam Ltd.
Survivin Sustains T Cell Expansion
629T Cells and APC
CD4+ T cells were purified from spleen and lymph nodes by nylon
wool depletion followed by antibody and complement treatment
(Song et al., 2004). The cells were >90% CD4+, and >95% of these
cells expressed the appropriate TCR and a naive phenotype. APCs
were from spleens of syngeneic nontransgenic mice by depleting
T cells. APCs were treated with mitomycin c (100 g/ml) for 30 min
at 37°C.
T Cell Cultures
Cultures were in 48-well plates containing 1 ml RPMI 1640 (Irvine
Scientific) with 10% fetal calf serum (Omega Scientific). Naive CD4
cells were plated at 5 × 105/ml with 2 × 106/ml APCs and various
concentrations of antigen. Agonist antibodies to OX40 (10 g/ml)
were added at 0 and 48 hr. For determining secondary responses,
5 × 105 T cells were recultured with 2 × 106 APCs per ml. LY294002
(5 M) or Wortmannin (10 nM) in DMSO was added at various
times. For cell cycle inhibition, DMSO, Hydroxyurea, Aphidicolin, or
Nocodazole was added at the initiation of cultures at 1–10 g/ml
concentrations predetermined to specifically block alternate phases
of the cell cycle. For protein synthesis inhibition, ethanol or cyclo-
hexamide was added at 0.03 M, a concentration that blocked
80%–85% of Survivin expression as measured by flow cytometry.
Retroviral Transduction
cDNA for human Survivin and mutant (T34A) Survivin were a kind
gift of Dr. Dario Altieri, Department of Cancer Biology, University of
Massachusetts Medical School. Murine stem cell virus IRES green
fluorescent protein (Mig) retroviral expression vectors containing
the cDNAs Mig-Survivin and Mig-T34-Survivin were constructed by
cloning into BglII and XhoI sites. Other vectors were used as de-
scribed (Rogers et al., 2001; Song et al., 2004). Active (myristoy-
lated) PKB (Mig-myr-PKB) and dominant-negative (K179M) PKB
(Mig-dn-PKB) both were kind gifts from Dr. L. Van Parijs. Retroviral
transduction was performed as before (Song et al., 2004). 5 ×105
T cells were stimulated with antigen and APCs. After 2 days, the
supernatant was replaced with 1 ml viral supernatant containing
5 g/ml Polybrene (Sigma), and the cells were spun for 3 hr at 32°C
and incubated at 32°C for 8 hr. This was repeated the following
day. Viral supernatant was removed and replaced with fresh me-
dium, and T cells were recultured. Expression of GFP was deter-
mined by flow cytometry gating on Vβ3+ or Vβ5+ T cells. GFP-
expressing T cells were purified by sorting with a FACS Vantage
SE I high-speed cell sorter (BD Immunocytometry Systems, San
Jose, CA).
Adoptive Transfer
T cells were cultured with antigen and transduced on day 2 and 3
with retroviral vectors (Song et al., 2004). Cells were recultured for
3 more days. GFP+ CD4 cells were sorted, in some cases labeled
with the dye PKH26, and 3.5 × 106 cells were injected i.v. into naive
mice. Mice were challenged i.p. with 100 g OVA or PCC in PBS or
with PBS without antigen. Numbers of T cells were calculated
based on total cell numbers in spleen and lymph nodes, together
with percentages of GFP+Vβ+ cells visualized from FACS.
Cytokine Secretion, Cell Recovery, Proliferation,
Cell Division, and Apoptosis
Cytokines were measured by ELISA (Song et al., 2004). T cell sur-
vival in vitro was determined by trypan blue exclusion. Proliferation
was measured in triplicate cultures by incorporation of 3H-thymi-
dine (1 Ci/well, ICN Pharmaceuticals) during the last 12 hr of cul-
ture. Cell division was assessed with a pulse of BrdU given i.p. for
48 hr in vivo or by prelabeling T cells with PKH26. Apoptosis was
assessed with annexin V conjugated to PE (BD Pharmingen).
Immunopreciptation and Immunoblotting
Live CD4 cells were recovered by Ficoll treatment and positive
selection with anti-CD4 microbeads (Miltenyi Biotec, Inc). Cells
were lysed in ice-cold RIPA Lysis Buffer (20 mM Tris-HCl [pH 7.5],
150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton X-100, 2.5
mM sodium pyrophosphate, 1 mM beta-glycerophosphate, 1 mM
Na VO4, and 1 g/ml leupeptin) for 30 min. Insoluble material was3removed and lysates were used for Western blotting or immuno-
precipitated overnight with anti-Survivin followed by incubation
with protein G agarose beads at 4°C for 2 hr. The washed immuno-
precipitates were boiled in SDS sample buffer. Protein content was
determined by Bio-Rad Protein Assay Kit (Bio-Rad, Hercules, CA).
Equal amounts (30–50 g) were loaded onto 4%–12% NuPage Bis-
Tris precasting gels (sodium dodecyl-sulfate-polyacrylamide gel
electrophoreses [SDS-PAGE]), transferred onto PVDF membrane
(Invitrogen), and immunoblotted. All blots were developed with the
ECL immunodetection system (Amersham Pharmacia Biotech, Pis-
cataway, NJ).
Real-Time RT-PCR
Quantitative reverse-transcriptase-polymerase chain reaction (RT-
PCR) was performed with SyBr Green I dye with an ABI GeneAmp
5700 sequence BioDetector (PE Biosystems, Foster City, CA). Total
RNA was extracted with Trizol (Invitrogen) and reverse transcribed
by using oligo(dT)12–18 (Super Script II, Invitrogen). Each transcript
was analyzed concurrently on the same plate with HPRT, and levels
of mRNA were normalized to HPRT abundance. Sequence-specific
primers for murine Survivin (forward primer, 5#-TACCGAGAACG
AGCCTGATT-3#; reverse primer, 5#-TGCTCCTCTATCGGGTTGTC-
3#); HPRT (forward primer, 5#-CTGGTGAAAAGGACCTCTCG-3#; re-
verse primer, 5#-TGAAGTACTCATTATAGTCAAGGGCA-3#).
Survivin Staining and Cell Cycle Analysis
For staining Survivin by flow cytometry, cells were fixed with
Cytofix/Cytoperm Solution (BD Pharmingen) for 30 min on ice,
washed with Perm/Wash Buffer (BD Pharmingen), and suspended
in 50 L Perm/Wash Buffer containing 1 g/mL either isotype con-
trol or affinity purified polyclonal anti-mouse Survivin (NB 500-201).
After 30 min, unbound antibody was removed by washing in Perm/
Wash Buffer, followed by Biotin-conjugated anti-rabbit immuno-
globulin and Streptavidin-PE (BD Pharmingen). Cell cycle analysis
was performed with a BrdU Flow kit (BD Pharmingen). Cells were
incubated with 10 M BrdU for the final 60 min of culture and then
were fixed and permeabilized. DNA was digested by incubation
with 300 g/mL of DNase for 1 hr at 37°C. BrdU-treated cells were
intracellularly stained with an anti-BrdU-FITC antibody and 7-amino-
actinomycin D (7-AAD). In some experiments, the cells were intra-
cellularly stained with BrdU and Survivin antibodies and then
7-AAD.
Supplemental Data
Supplemental Data including two figures are available online with
this article at http://www.immunity.com/cgi/content/full/22/5/621/
DC1/.
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